Recent studies show that SHP2 inhibition or deletion in macrophages exacerbates atherosclerosis in ApoE−/− and Ldlr−/− mice by increasing inflammation, impairing efferocytosis, and destabilizing plaques. Here, LDLR is linked to atherosclerosis.